BTWNU $10.11 -0.001%
ADX $15.53 -0.3312%
DGRO $49.47 -0.5028%
ALGLD.PA $1.82 40%
0UNV.L $0.33 -4.3478%
EMXF $34.46 -1.012%
BPYU $18.52 0%
SHCR $1.46 -1.0204%
1970.HK $6.75 1.0479%
AKRO $45.41 -0.4167%
SKM $20.76 -1.1667%
MCW $9.16 -1.6112%
APAM $31.90 -1.7555%
RCFA $10.51 0%
RAAX $24.86 -0.3808%
1655.HK $0.58 0%
XSW $115.16 -1.3888%
CTA $24.88 0.0809%
GLRY $23.75 0.5262%
PSNY $3.31 -4.8921%
FDIV $49.00 9.26628%
RRD $10.84 0%
CHSCM $24.57 -0.5401%
RGS $1.00 -1.9608%
BPRN $24.14 -1.4694%
XSNR.L $10 977.00 -9.71377%
AAL.L $2 337.50 -0.426%
ALF.L $0.03 -37.7778%
FLSP $21.29 -0.5605%
FRAK $157.50 0%
ZOE.L $37.63 0%
9997.HK $9.20 -2.439%
ADOC $10.86 0%
DCOM $15.73 -2.2685%
EPR-PC $19.04 -1.2341%
APDN $1.07 -0.7037%
TRKA $0.19 10.82%
ESTA $66.65 -4.9487%
ALORW $0.04 0%
EBRO.MC $16.90 -0.4711%
TOPS $0.73 -0.6803%
SCE-PJ $19.41 0.7006%
MBOT $1.17 10.3774%
CSD $54.13 -0.2929%
TQ5.SI $0.89 1.1429%
AIHS $0.89 -3.0986%
UC90.L $12 508.00 0.353%
EEUE.PA $13.73 0.5565%
IUAG.L $95.55 -0.3338%
RRR $45.51 1.1333%
TSE $12.93 -6.032%
1338.HK $0.05 6.383%
DCRNU $9.80 0%
ITXT.PA $3.00 0%
CERE $31.51 -0.0634%
FGF $2.36 0.4119%
3143.HK $7.03 -1.0563%
FINU $24.33 0%
MYN $10.04 -0.0348%
SNIK.L $4.51 2.1614%
AFG $115.50 -0.431%
NEGG $1.08 -1.3761%
TEET.L $72.32 4.486%
OCAXU $10.04 -3.5543%
FEUZ $38.76 -0.9329%
ADIL $0.31 -2.1488%
SMMU $49.65 -0.0503%
CDZI $4.24 -1.8519%
DUK $97.18 -0.1541%
AIGE.L $3.38 -1.5174%
COCO.L $2.94 0.1533%
EVLMC $99.96 0%
SNLN $14.61 0%
CCAI $10.30 -0.9615%
ESEH.PA $13.71 -0.1994%
INO $0.71 -9.7934%
KALU $59.84 -0.5898%
SRG $7.51 0.267%
DCI.L $3.70 -2.6316%
6069.HK $6.16 -0.1621%
1608.HK $0.37 -1.3514%
TBBK $28.54 0.158%
SNSY3.SA $4.34 0%
STBX $3.44 -1.7143%
VIOT $0.82 1.1721%
CLIM $10.02 0%
PFSW $4.02 -1.8337%
LKFN $43.30 -0.3452%
CYN.L $171.00 0.1464%
VAW $170.44 -0.4614%
FCOR $45.96 -0.3253%
TAEE4.SA $12.43 0.6478%
ECOM $23.09 0%
UGRO $1.33 2.3077%
BZFD $0.53 -1.9071%
2218.HK $6.37 -0.313%
EW $88.73 -0.062%
CALM $47.21 -1.4405%
0P0000KM1Y.L $26 712.60 -0.0737%
GPL $0.19 0%
Eng
Логотип
Eng
Лого

BiVictriX Therapeutics Plc BVX.L

$15.00

На 18:04, 12 мая 2023

Ключевые показатели

  • Marketcap

    9917280.00000000

  • week52high

    25.30

  • week52low

    15.00

  • Revenue

    0

  • P/E TTM

    -397

  • Beta

    0.00000000

  • EPS

    -0.04000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    30 мар 2023 г. в 06:00

Описание компании

BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia. The company was formerly known as BiVictriX Plc and changed its name to BiVictriX Therapeutics Plc in August 2021. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек